Kang Huafeng相关文献与解析，生知库 | 链接生命科学的每一步

Zhai, Zhen; Wu, Jinpeng; Wei, Yumeng; Song, Ping; Wang, Meng; Lin, Shuai; Ma, Xiaobin; Lu, Yurong; Yang, Pengbo; Tan, Zengqi; Guan, Feng; Li, Xiang; Kang, Huafeng

肿瘤

肿瘤免疫

信号转导

Bispecific Antibody Targeting VEGF/TGF-Î² Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects.

靶向 VEGF/TGF-β 的双特异性抗体与局部放射疗法协同作用：将肿瘤从冷肿瘤转变为炎症肿瘤，并增强远隔效应

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202501819

Lyu Lijuan, Yi Ming, Chen Ji, Zhang Jing, Ma Xiaobin, Zhang Xiaojun, Zeng Liang, Xue Yan, Wen Haimei, Deng Yujiao, Zhou Pengfei, Wu Kongming, Kang Huafeng, Dai Zhijun

Bisecting GlcNAc enhances CD8(+) T cell-mediated killing of breast cancer by suppressing PD-L1 expression and its binding to PD-1.

二分 GlcNAc 通过抑制 PD-L1 表达及其与 PD-1 的结合，增强 CD8(+) T 细胞介导的乳腺癌杀伤作用

期刊:Experimental Hematology & Oncology

影响因子:13.5

doi:10.1186/s40164-025-00693-w

Ren Xueting, Wu Jinpeng, Li Jing, Zhai Zhen, Li Xiang, Guan Feng, Wang Meng, Ma Xiaobin, Tan Zengqi, Kang Huafeng, Lin Shuai

A novel glycogene-related signature for prognostic prediction and immune microenvironment assessment in kidney renal clear cell carcinoma.

一种用于肾透明细胞癌预后预测和免疫微环境评估的新型糖基因相关特征

期刊:Annals of Medicine

影响因子:4.3

doi:10.1080/07853890.2025.2495762

Zhao Xuyan, Cui Hanxiao, Zhou Mingjing, Ren Xueting, Li Zihao, Liu Peinan, Zhao Danni, Lin Shuai, Kang Huafeng

细胞生物学

发表日期：2025

文献求助收藏

Smoking cessation improves health status of patients with chronic diseases: evidence from a longitudinal study of older adults in China

戒烟改善慢性病患者的健康状况：来自中国老年人纵向研究的证据

期刊:BMC Public Health

影响因子:3.6

doi:10.1186/s12889-025-22203-7

Zhu, Haoyu; Xu, Peng; Wei, Yumeng; Zhao, Chuchen; Zhao, Danni; Li, Yaxin; Ma, Xiaobin; Wang, Meng; Kang, Huafeng

发表日期：2025

文献求助收藏

Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy

糖基化靶向治疗：癌症免疫疗法的范式转变

期刊:International Journal of Biological Sciences

影响因子:10

doi:10.7150/ijbs.93806

Ren, Xueting; Lin, Shuai; Guan, Feng; Kang, Huafeng

Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer

评估新辅助化疗对临床T1期三阴性乳腺癌的疗效

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-024-68719-7

Hao, Qian; Dai, Luyao; Chang, Lidan; Song, Dingli; Liu, Dandan; Ma, Xiaobin; Wu, Hao; Kang, Huafeng

Choice of wedge resection for selected T1a/bN0M0 non-small cell lung cancer

对于部分T1a/bN0M0期非小细胞肺癌，可选择楔形切除术。

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-024-76413-x

Xu, Zhengshui; Ma, Zhenchuan; Zhao, Feng; Li, Jianzhong; Kong, Ranran; Li, Shaomin; Jiang, Jiantao; Kang, Huafeng; Liu, Dandan

Favorable outcome of neoadjuvant endocrine treatment than surgery-first in female HR-positive/HER2-negative breast cancer patients-A NCDB analysis (2010-2016)

对于 HR 阳性/HER2 阴性乳腺癌女性患者，新辅助内分泌治疗比先手术治疗效果更佳——NCDB 分析（2010-2016 年）

期刊:Cancer Medicine

影响因子:3.1

doi:10.1002/cam4.7244

Xu, Peng; Luo, Wen; Hu, Jingjing; Ma, Xiaobin; Hao, Qian; Hui, Wentao; Zhou, Zhangjian; Lin, Shuai; Wang, Meng; Wu, Hao; Dai, Zhijun; Kang, Huafeng

Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?

对于接受保乳手术的 T2N0-1M0 期激素受体阳性/HER2 阴性乳腺癌患者，新辅助化疗是否必要？

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-024-05810-6

Liu, Dandan; Chang, Lidan; Hao, Qian; Ren, Xueting; Liu, Peinan; Liu, Xingyu; Wei, Yumeng; Wang, Meng; Wu, Hao; Kang, Huafeng; Lin, Shuai

O-GlcNAcylation regulates the DNA damage repair function of MND1 in breast cancer

O-GlcNAc糖基化调控MND1在乳腺癌中的DNA损伤修复功能

Bispecific Antibody Targeting VEGF/TGF-Î² Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects.

靶向 VEGF/TGF-β 的双特异性抗体与局部放射疗法协同作用：将肿瘤从冷肿瘤转变为炎症肿瘤，并增强远隔效应

Bisecting GlcNAc enhances CD8(+) T cell-mediated killing of breast cancer by suppressing PD-L1 expression and its binding to PD-1.

二分 GlcNAc 通过抑制 PD-L1 表达及其与 PD-1 的结合，增强 CD8(+) T 细胞介导的乳腺癌杀伤作用

A novel glycogene-related signature for prognostic prediction and immune microenvironment assessment in kidney renal clear cell carcinoma.

一种用于肾透明细胞癌预后预测和免疫微环境评估的新型糖基因相关特征

Smoking cessation improves health status of patients with chronic diseases: evidence from a longitudinal study of older adults in China

戒烟改善慢性病患者的健康状况：来自中国老年人纵向研究的证据

Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy

糖基化靶向治疗：癌症免疫疗法的范式转变

Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer

评估新辅助化疗对临床T1期三阴性乳腺癌的疗效

Choice of wedge resection for selected T1a/bN0M0 non-small cell lung cancer

对于部分T1a/bN0M0期非小细胞肺癌，可选择楔形切除术。

Favorable outcome of neoadjuvant endocrine treatment than surgery-first in female HR-positive/HER2-negative breast cancer patients-A NCDB analysis (2010-2016)

对于 HR 阳性/HER2 阴性乳腺癌女性患者，新辅助内分泌治疗比先手术治疗效果更佳——NCDB 分析（2010-2016 年）

Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?

对于接受保乳手术的 T2N0-1M0 期激素受体阳性/HER2 阴性乳腺癌患者，新辅助化疗是否必要？